Formulation Development
Our scientists use Quality-By-Design (QbD) tools at all stages of formulation development. Design of experiments (DOE) along with risk assessment strategies allows us to design our experimental plan. Our development approach allows us to meet our delivery timelines and helps us in providing our clients with cost-effective drug delivery solutions
Dosage forms
- Tablets : Immediate-release, Sustained-release, Delayed-release, Film-coated, Layered tablet
- Capsules : Powder, Granule filling
- Parenteral: Solutions, Suspensions, Emulsions, infusions
- Ophthalmic: Solutions, Suspensions, Emulsions
- Pellets : Into tablets or Capsule filled
- Powders : Powder in a bottle, Powder for Injection
- Liquids : Solutions, Suspensions, Emulsions
- Semi-solids : Creams, Ointments, Gels, Lotions
Formulation Technologies
- Dry blending
- High shear granulation
- Fluid bed granulation
- Roller compaction
- Extrusion spheronisation
- Wurster coating
- Spray drying
- Micronization
- Pan Coating
- Encapsulation
- Injectable lyophilisation
- Injectable depot formulation
Formulation development Specialties
- Generic products
- First Generic products
- Complex Generics
- Niche Generics
- NCE formulation
- Life Cycle Management projects
- 505(b)2 submissions
- Enabling formulations and Late stage clinical formulations
Equipment And Process Capabilities
- Direct Tablet Compression
- Fluid Bed Processing (Granulation, Drying, Coating)
- High Shear Wet Granulation
- Dry Granulation (Roller Compaction, Slugging)
- Extrusion Spheronization
- Perforated Pan Tablet Coating
- Automated Capsule Filling (Powder, Granules, Pellets)
- Spray Drying
- Microencapsulation
- Low Humidity / Moisture Requirements
- Taste-Masking
- High Potency Compound Handling
- Instrumented Tablet Press
- Lyophilizer